COL7A1 and Nail dystrophy: Fritsch [16] created a transgenic mouse model with contingent inactivation of COl7A1 expression, resulting in a COl7A1 hypomorphic animal expressing about 10% of normal COl7A1 and clinical symptoms that closely resemble human recessive abnormalities, such as nail dystrophy, skin fragility, and growth failure.